Colloid fluids

Clinical Fluid Therapy in the Perioperative Setting

Volumn , Issue , 2011, Pages 11-17

  Hahn, Robert G ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84917735936     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511733253.003     Document Type: Chapter

References (23)

1. Hedin A, Hahn RG. Volume expansion and plasma protein clearance during intravenous infusion of 5% albumin and autologous plasma. Clin Sci 2005; 106: 217–224.
2. Marik P E. The treatment of hypoalbuminemia in the critically ill patient. Heart Lung 1993; 22: 166–170.
3. Guthrie RD, Hines C. Use of intravenous albumin in the critically ill patient. Am J Gastroenterol 1991; 86: 255–263.
4. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised trials. BMJ 1998; 317: 235–240.
5. Roberts I, Edwards P, McLelland B. More on albumin. Use of human albumin in UK fell substantially when systematic review was published (letter). BMJ1999; 318: 1214–1215.
6. Wilkes M M, Navickis R J. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med2001; 135: 149–164.
7. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New Engl J Med2004; 350: 2247–2256.
8. The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New Engl J Med2007; 357: 874–884.
9. Svensén C, Hahn RG. Volume kinetics of Ringer solution, dextran 70 and hypertonic saline in male volunteers. Anesthesiology1997; 87: 204–212.
10. Hahn RG. Dextran 70 and the blood loss during transurethral resection of the prostate. Acta Anaesthesiol Scand1996; 40: 820–824.
11. Drobin D, Hahn RG. Kinetics of isotonic and hypertonic plasma volume expanders. Anesthesiology2002; 96: 1371–1380.
12. Christensen P, Andersson J, Rasmussen S E, Andersen P K, Henneberg S W. Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients. Acta Anaesthesiol Scand2001; 45: 414–420.
13. Lehmann GB, Asskali F, Boll M, et al. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth2007; 98: 635–644.
14. Voluven 6% hydroxyethyl starch 130/0.4 product monograph. Bad Homburg (Germany), Fresenius Kabi, 2007.
15. Ickx BE, Bepperling F, Melot C, Schulman C, vander Linden PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemo dilution. Br J Anaesth2003; 91: 196–202.
16. Schortgen F, Lacherade LC, Bruneel F, et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet2001; 357: 911–916.
17. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med2008; 358: 125–138.
18. Béchir M, Puhan MA, Nef SB, et al. Early fluid resuscitation with hyperoncotic hydroxyethyl starch 200/0.5 (10%) in severe burn injury. Crit Care2010; 14: 123.
19. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence risk factor mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanimat1994; 13: 301–10.
20. Hahn RG. Volume kinetics of infusion fluids (review). Anesthesiology2010; 113: 470–481.
21. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery1989; 105: 65–71.
22. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ1998; 316: 961–964.
23. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systemtic review. Crit Care Med1999; 27: 200–210.